Decision

Advertising investigations: August 2018

Decisions made by MHRA following investigations into complaints about advertising for licensed medicines.

Documents

June and July 2018 List of Clinics advertising botulinum toxin products

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Promotion of Covonia

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Contact advertising@mhra.gov.uk if you have concerns with the advertising of medicines or write to:

Advertising Standards Unit,
151 Buckingham Palace Road
Victoria
London SW1W 9SZ

Alternatively, contact the pharmaceutical self-regulatory bodies, the Proprietary Association of Great Britain (PAGB) for advertising for over the counter medicines, or the Prescription Medicines Code of Practice Authority (PMCPA) for advertisements to health professionals for prescription medicines.

See the Blue Guide for guidance on how medicines should be promoted or advertised in the UK.

Published 7 September 2018